156 related articles for article (PubMed ID: 3129438)
41. Association of intermediate filaments with vinculin-containing adhesion plaques of fibroblasts.
Bershadsky AD; Tint IS; Svitkina TM
Cell Motil Cytoskeleton; 1987; 8(3):274-83. PubMed ID: 3121191
[TBL] [Abstract][Full Text] [Related]
42. Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes.
Seishima M; Satoh S; Nojiri M; Osada K; Kitajima Y
J Invest Dermatol; 1997 Nov; 109(5):650-5. PubMed ID: 9347794
[TBL] [Abstract][Full Text] [Related]
43. The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae.
Stahl A; Mueller BM
J Cell Biol; 1995 Apr; 129(2):335-44. PubMed ID: 7721938
[TBL] [Abstract][Full Text] [Related]
44. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.
Jankun J; Maher VM; McCormick JJ
Cancer Res; 1991 Feb; 51(4):1221-6. PubMed ID: 1847659
[TBL] [Abstract][Full Text] [Related]
45. Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.
Kindzelskii AL; Amhad I; Keller D; Zhou MJ; Haugland RP; Garni-Wagner BA; Gyetko MR; Todd RF; Petty HR
Histochem Cell Biol; 2004 Apr; 121(4):299-310. PubMed ID: 15042374
[TBL] [Abstract][Full Text] [Related]
46. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.
Carriero MV; Franco P; Del Vecchio S; Massa O; Botti G; D'Aiuto G; Stoppelli MP; Salvatore M
Cancer Res; 1994 Oct; 54(20):5445-54. PubMed ID: 7923178
[TBL] [Abstract][Full Text] [Related]
47. Colocalization of F-actin and 34-kilodalton actin bundling protein in Dictyostelium amoebae and cultured fibroblasts.
Johns JA; Brock AM; Pardee JD
Cell Motil Cytoskeleton; 1988; 9(3):205-18. PubMed ID: 3284657
[TBL] [Abstract][Full Text] [Related]
48. Differential response of myofibrillar and cytoskeletal proteins in cells treated with phorbol myristate acetate.
Lin ZX; Eshleman J; Grund C; Fischman DA; Masaki T; Franke WW; Holtzer H
J Cell Biol; 1989 Mar; 108(3):1079-91. PubMed ID: 2493458
[TBL] [Abstract][Full Text] [Related]
49. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
[TBL] [Abstract][Full Text] [Related]
50. Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids.
Medcalf RL; Richards RI; Crawford RJ; Hamilton JA
EMBO J; 1986 Sep; 5(9):2217-22. PubMed ID: 3780677
[TBL] [Abstract][Full Text] [Related]
51. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
Marschall C; Lengyel E; Nobutoh T; Braungart E; Douwes K; Simon A; Magdolen V; Reuning U; Degitz K
J Invest Dermatol; 1999 Jul; 113(1):69-76. PubMed ID: 10417621
[TBL] [Abstract][Full Text] [Related]
52. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro.
Ando Y; Jensen PJ
J Cell Physiol; 1996 Jun; 167(3):500-11. PubMed ID: 8655604
[TBL] [Abstract][Full Text] [Related]
53. Increase of urokinase-type plasminogen activator receptor expression in human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide.
Ogura N; Nagura H; Abiko Y
J Periodontol; 1999 Apr; 70(4):402-8. PubMed ID: 10328652
[TBL] [Abstract][Full Text] [Related]
54. Studies on proteins that co-purify with smooth muscle vinculin: identification of immunologically related species in focal adhesions of nonmuscle and Z-lines of muscle cells.
Wilkins JA; Risinger MA; Lin S
J Cell Biol; 1986 Oct; 103(4):1483-94. PubMed ID: 3095336
[TBL] [Abstract][Full Text] [Related]
55. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
[TBL] [Abstract][Full Text] [Related]
56. Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion.
Frixen UH; Nagamine Y
Cancer Res; 1993 Aug; 53(15):3618-23. PubMed ID: 8339268
[TBL] [Abstract][Full Text] [Related]
57. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
58. Purification and characterization of tissue plasminogen activator secreted by human embryonic lung diploid fibroblasts, IMR-90 cells.
Itagaki Y; Yasuda H; Morinaga T; Mitsuda S; Higashio K
Agric Biol Chem; 1991 May; 55(5):1225-32. PubMed ID: 1368681
[TBL] [Abstract][Full Text] [Related]
59. Formation of stress fibres and focal adhesion sites in monensin-exposed cultured human fibroblasts in response to exogenously added cellular fibronectin.
Lehto VP; Virtanen I
Exp Cell Res; 1985 Jun; 158(2):563-9. PubMed ID: 3924643
[TBL] [Abstract][Full Text] [Related]
60. Vinculin interaction with permeabilized cells: disruption and reconstitution of a binding site.
Ball EH; Freitag C; Gurofsky S
J Cell Biol; 1986 Aug; 103(2):641-8. PubMed ID: 3090053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
